Icosagen

About Icosagen

Icosagen is a private, independent family-business, advancing therapeutic proteins from mammalian cells since 26 years.

As CRDMO, we uniquely combine pre-clinical CRO and clinical CDMO capabilities at one site, advancing molecules from discovery through R&D stages, into stable IcoCell® CHO cell lines and GMP manufacturing. From mAbs, complex multi-specifics to ADCs or recombinant pr...

Certifications
  • Country/Region:
    Estonia
  • On CPHI since:
    2024
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
Biopharmaceutical company
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
Contact info

Products from Icosagen (3)

  • Clinical CDMO

    Product Clinical CDMO

    - Under one single roof together with discovery and pre-clinical CRO departments, capitalizing on the previously in-house gained molecule know-how, intact project teams and existing legal agreements - Stable, proprietary IcoCell® CHO cell line development platform with competitive titers & timelines, fee-...
  • Pre-Clinical CRO

    Product Pre-Clinical CRO

    - Transient protein production CHO (& HEK) from proprietary QMCF expression platform - Hundreds of protein candidates in parallel - From mgs to grams, from ml’s to dozens of liters scale (chemically defined, serum-free medium) - Protein for in-vitro and in-vivo purposes - Automated, high-throughput pla...
  • Antibody DISCOVERY

    Product Antibody DISCOVERY

    - Antigen protein production in HEK & CHO - Antibody discovery in chicken, rabbits, alpaca VVH’s and by Phage Display in vitro - Functional antibody discovery against integral multi-pass transmembrane protein (such as transporters, GPCRs, & ion channels) by proprietary pseudotyped VLP-based display techn...